Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.Abstract:
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agentsread more
Citations
More filters
Journal ArticleDOI
Caffeic Acid Phenethyl Ester as a Potential Treatment for Advanced Prostate Cancer Targeting Akt Signaling
Hui-Ping Lin,Ching-Yu Lin,Chun-Chieh Liu,Liang-Cheng Su,Chieh Huo,Ying-Yu Kuo,Jen-Chih Tseng,Jong-Ming Hsu,Chi-Kuan Chen,Chih-Pin Chuu +9 more
TL;DR: The potential of using CAPE as a treatment for patients with advanced prostate cancer targeting Akt signaling pathway is discussed in this review article.
Journal ArticleDOI
In vivo and in vitro approaches to study metastasis in human prostatic cancer.
TL;DR: The variousin vivo andin vitro approaches described in the present chapter make it possible to enrich site-specific variants of different prostatic cancer cell lines for further characterization and elucidation of the molecular mechanisms underlying metastasis in prostate cancer.
Journal Article
Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
TL;DR: As is the case with anti-CF serum, anti-rTNF serum inhibited drug-dependent cellular cytotoxicity and cytolysis mediated by both freshly isolated monocytes and in vitro cultured unactivated and lymphokine-lipopolysaccharide activated monocytes, indicating that TNF is an effector molecule in both drug- dependent cellular cyttoxicity and "classical" monocyte-mediated cytot toxicity.
Journal ArticleDOI
Effects of the polyamine analogues BE-4-4-4-4, BE-3-7-3, and BE-3-3-3 on the proliferation of three prostate cancer cell lines.
TL;DR: The results show the polyamine analogues BE-4-4 -4- 4-4, BE-3-2-3 and BE- 3-7-3 to be effective inhibitors of prostate cancer cell growth in vitro and BE be an effective inhibitor of DU145 cells in vivo with minimal toxicity.
Journal ArticleDOI
Effects on prostate cancer cells of targeting RNA polymerase III.
John L. Petrie,Caroline Swan,Richard Ingram,Fiona M. Frame,Anne T. Collins,Hélène Dumay-Odelot,Martin Teichmann,Norman J. Maitland,Robert J. White +8 more
TL;DR: Untransformed prostate cells appear less sensitive than cancer cells to pol III depletion or inhibition, raising the possibility of a therapeutic window.